Screening for apparent total nitrosamine content with a thermal energy analyzer offers a rapid way of identifying contaminated drug products.
Andrew James
Advertisement
Andrew James is marketing director, Ellutia Limited.
Articles by Andrew James
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5